Log in

ASX:IDXIntegral Diagnostics Stock Price, Forecast & News

-0.01 (-0.30 %)
(As of 05/13/2020)
Today's Range
Now: A$3.31
50-Day Range
MA: A$3.31
52-Week Range
Now: A$3.31
Volume240,828 shs
Average VolumeN/A
Market Capitalization$644.40 million
P/E Ratio26.27
Dividend Yield2.60%
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia. The company provides its services through a network of 53 sites under the Lake Imaging, South Coast Radiology, and Global Diagnostics brands in Victoria, Queensland, and Western Australia, as well as through specialist Radiology Group, and Trinity MRI and Cavendish Radiology in Auckland, New Zealand. Integral Diagnostics Limited is headquartered in North Melbourne, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostics & Research
Phone61 3 5339 0704



Sales & Book Value

Annual Sales$249.55 million
Cash FlowA$0.14 per share
Book ValueA$1.16 per share



Market Cap$644.40 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IDX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDX and its competitors with MarketBeat's FREE daily newsletter.

Integral Diagnostics (ASX:IDX) Frequently Asked Questions

How has Integral Diagnostics' stock been impacted by COVID-19 (Coronavirus)?

Integral Diagnostics' stock was trading at A$3.74 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IDX shares have decreased by 11.5% and is now trading at A$3.31. View which stocks have been most impacted by Coronavirus.

How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?

Integral Diagnostics declared a Interim dividend on Friday, February 21st. Stockholders of record on Tuesday, April 7th will be paid a dividend of 0.055 per share on Tuesday, April 7th. This represents a dividend yield of 1.29%. The ex-dividend date of this dividend is Friday, February 28th. This is a positive change from Integral Diagnostics's previous Interim dividend of A$0.05. View Integral Diagnostics' dividend history.

Has Integral Diagnostics been receiving favorable news coverage?

News coverage about IDX stock has been trending negative this week, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Integral Diagnostics earned a media sentiment score of -2.5 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the near term. View the latest news about Integral Diagnostics.

Who are some of Integral Diagnostics' key competitors?

What other stocks do shareholders of Integral Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integral Diagnostics investors own include Westgold Resources (WGX), NRW (NWH), EML Payments (EML) and Bathurst Resources (BRL).

Who are Integral Diagnostics' key executives?

Integral Diagnostics' management team includes the following people:
  • Dr. Ian Kadish, CEO, MD & Director (Age 56)
  • Ms. Anne Lockwood, Chief Financial Officer
  • Dr. Chien Ping Ho, Exec. Director
  • Dr. Sally Sojan, Exec. Director
  • Mrs. Kathryn Davies BBus, GAICD, CPA, Company Sec.

What is Integral Diagnostics' stock symbol?

Integral Diagnostics trades on the ASX under the ticker symbol "IDX."

What is Integral Diagnostics' stock price today?

One share of IDX stock can currently be purchased for approximately A$3.31.

How big of a company is Integral Diagnostics?

Integral Diagnostics has a market capitalization of $644.40 million and generates $249.55 million in revenue each year. Integral Diagnostics employs 928 workers across the globe.

What is Integral Diagnostics' official website?

The official website for Integral Diagnostics is www.integraldiagnostics.com.au.

How can I contact Integral Diagnostics?

The company can be reached via phone at 61 3 5339 0704.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.